Active Research Protocols
- 08-C-0015 – A Phase II Trial of Enzastaurin (LY317615) in Combination with Bevacizumab in Adults with Recurrent Malignant Gliomas
- 08-C-0101 – A Phase 2 Trial of Tandutinib in Combination with Bevacizumab for Patients with Recurrent High-Grade Gliomas
- 09-C-0080 – A Phase 2, Open-label, Proof-of-Concept Study to Assess the Ability to Detect Tumours and Angiogenesis via the Expression of Alpha v Beta 3 Integrin Receptors by (18F)AH-111585 PET Imaging
- 11-C-0036 – A Pilot Study of Inpatient Hospice with Procurement of Brain Tumor Tissue on Expiration for Research Purposes
- 11-C-0122 – Phase I Trial of AZD8055, An Oral MTOR Kinase Inhibitor, for Adults with Recurrent Gliomas
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014